Total assets · 2011–2025
Halozyme Therapeutics total assets
$2.5B+22.4% · FY2025
Halozyme Therapeutics (HALO) reported $2.5B in total assets for fiscal 2025, +22.4% year on year.
| Fiscal year | Total assets | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $2.5B | +22.4% | Open → |
| FY20242024-12-31 | $2.1B | +19.1% | Open → |
| FY20232023-12-31 | $1.7B | −5.9% | Open → |
| FY20222022-12-31 | $1.8B | +66.7% | Open → |
| FY20212021-12-31 | $1.1B | +90.4% | Open → |
| FY20202020-12-31 | $580M | +2.5% | Open → |
| FY20192019-12-31 | $566M | +28.5% | Open → |
| FY20182018-12-31 | $440M | −15.3% | Open → |
| FY20172017-12-31 | $520M | +98.8% | Open → |
| FY20162016-12-31 | $262M | +43.9% | Open → |
| FY20152015-12-31 | $182M | +9.5% | Open → |
| FY20142014-12-31 | $166M | +63.1% | Open → |
| FY20132013-12-31 | $102M | −24.4% | Open → |
| FY20122012-12-31 | $135M | +104.9% | Open → |
| FY20112011-12-31 | $65.8M | — | Open → |
Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +29.8%
Total assets at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Halozyme Therapeutics total assets |url=https://companiesranked.com/en/company/halozyme-therapeutics/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Halozyme Therapeutics total assets. CompaniesRanked. https://companiesranked.com/en/company/halozyme-therapeutics/total-assetsBibTeX
@misc{companiesranked-en-company-halozyme-therapeutics-total-assets-2026,
author = {{CompaniesRanked}},
title = {{Halozyme Therapeutics total assets}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/halozyme-therapeutics/total-assets}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001159036-26-000104 · August 6, 2026
{{cite web |title=Halozyme Therapeutics total assets — 10-Q (0001159036-26-000104) |url=https://www.sec.gov/Archives/edgar/data/1159036/000115903626000104/halo-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.